eHealth Delivery Alternative for Cancer Genetic Testing for Hereditary Cancer

NCT ID: NCT05427240

Last Updated: 2025-11-14

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

1000 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-09-28

Study Completion Date

2026-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This randomized non-inferiority study will use a 2x2 design where traditional standard-of-care pre-test (visit 1) and post-test (visit 2: disclosure) counseling delivered by a genetic counselor are replaced with a self-directed web-based eHealth intervention to provide critical data to inform optimal ways to deliver clinical genetic testing in eligible individuals, while maintaining quality of care and favorable cognitive, affective and behavioral outcomes.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Germline cancer genetic testing has become a standard evidence-based practice, with established risk reduction and cancer screening guidelines for genetic carriers. Access to genetic specialists is limited in many areas in the US, and the traditional medical delivery model of pre- and post-test counseling with a genetic professional will not support the rising indications for genetic testing. Recent data from the National Health Interview Survey found that \<20% of eligible patients with a personal or family history of breast or ovarian cancer underwent genetic testing. Thus, there is an urgent need to consider alternative delivery models to increase access and uptake of genetic testing, while maintaining adequate patient cognitive, affective and behavioral outcomes.

This study aims to evaluate the effectiveness of offering web-based eHealth delivery alternatives of pre/post-test genetic counseling to provide equal or improved timely uptake of genetic services and testing, and short-term cognitive (e.g. understanding), affective (e.g. distress and uncertainty) and behavioral (risk reducing and screening behaviors and communication to providers and relatives) outcomes in patients with barriers to genetic testing as compared to the traditional two-visit delivery model with a genetic counselor.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cancer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

ARM A

Visit 1/Pre-Test Session - Standard-of-Care Pre-Test Counseling with a genetic counselor.

Visit 2/Disclosure Session - Standard-of-Care Post-Test Counseling with a genetic counselor.

Group Type EXPERIMENTAL

Standard of Care

Intervention Type OTHER

Standard of Care with a Genetic Counselor by Remote Services

ARM B

Visit 1/Pre-Test Session - Standard-of-Care Pre-Test Counseling with a genetic counselor.

Visit 2/Disclosure Session - Self-directed web-based eHealth result disclosure intervention.

Group Type EXPERIMENTAL

Pre-Test Intervention

Intervention Type OTHER

Secure and accessible by private code only, the web-based intervention will provide users with a the results of their clinical genetic testing results and a detailed summary of what those results mean. Additionally, an individualized summary will also be included.

Standard of Care

Intervention Type OTHER

Standard of Care with a Genetic Counselor by Remote Services

ARM C

Visit 1/Pre-Test Session - Self-directed web-based eHealth pre-test session intervention.

Visit 2/Disclosure Session - Standard-of-Care Post-Test Counseling with a genetic counselor.

Group Type EXPERIMENTAL

Standard of Care

Intervention Type OTHER

Standard of Care with a Genetic Counselor by Remote Services

Post-Test Intervention

Intervention Type OTHER

Secure and accessible by private code only, the web-based intervention will provide users with a the results of their clinical genetic testing results and a detailed summary of what those results mean. Additionally, an individualized summary will also be included.

ARM D

Visit 1/Pre-Test Session - Self-directed web-based eHealth pre-test session intervention.

Visit 2/Disclosure Session - Self-directed web-based eHealth result disclosure intervention.

Group Type EXPERIMENTAL

Pre-Test Intervention

Intervention Type OTHER

Secure and accessible by private code only, the web-based intervention will provide users with a the results of their clinical genetic testing results and a detailed summary of what those results mean. Additionally, an individualized summary will also be included.

Post-Test Intervention

Intervention Type OTHER

Secure and accessible by private code only, the web-based intervention will provide users with a the results of their clinical genetic testing results and a detailed summary of what those results mean. Additionally, an individualized summary will also be included.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Pre-Test Intervention

Secure and accessible by private code only, the web-based intervention will provide users with a the results of their clinical genetic testing results and a detailed summary of what those results mean. Additionally, an individualized summary will also be included.

Intervention Type OTHER

Standard of Care

Standard of Care with a Genetic Counselor by Remote Services

Intervention Type OTHER

Post-Test Intervention

Secure and accessible by private code only, the web-based intervention will provide users with a the results of their clinical genetic testing results and a detailed summary of what those results mean. Additionally, an individualized summary will also be included.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 18 years of age or older
* Speak and understand English
* Male or Female
* No prior germline genetic testing
* Meet current National Comprehensive Cancer Network (NCCN) guidelines for germline genetic testing

Exclusion Criteria

-Communication difficulties such as:

* Uncorrected or uncompensated hearing and/or vision impairment
* Uncorrected or uncompensated speech defects
* Uncontrolled psychiatric/mental condition or severe physical, neurological or cognitive deficits rendering individual unable to understand study goals and tasks
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Fox Chase Cancer Center

OTHER

Sponsor Role collaborator

National Cancer Institute (NCI)

NIH

Sponsor Role collaborator

Abramson Cancer Center at Penn Medicine

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Angela R Bradbury, MD

Role: PRINCIPAL_INVESTIGATOR

University of Pennsylvania

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Abramson Cancer Center at the University of Pennsylvania

Philadelphia, Pennsylvania, United States

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Angela R Bradbury, MD

Role: CONTACT

Phone: 215 615 3341

Email: [email protected]

Dominique Fetzer, BA

Role: CONTACT

Phone: 215 662 2753

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Angela Bradbury, MD

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

850242

Identifier Type: OTHER

Identifier Source: secondary_id

13021

Identifier Type: -

Identifier Source: org_study_id